Matches in Wikidata for { <http://www.wikidata.org/entity/Q37739656> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q37739656 description "article científic" @default.
- Q37739656 description "article scientifique" @default.
- Q37739656 description "articolo scientifico" @default.
- Q37739656 description "artigo científico" @default.
- Q37739656 description "artículu científicu espublizáu en 2010" @default.
- Q37739656 description "bilimsel makale" @default.
- Q37739656 description "scientific article published on 28 April 2010" @default.
- Q37739656 description "vedecký článok" @default.
- Q37739656 description "vetenskaplig artikel" @default.
- Q37739656 description "videnskabelig artikel" @default.
- Q37739656 description "vědecký článek" @default.
- Q37739656 description "wetenschappelijk artikel" @default.
- Q37739656 description "wissenschaftlicher Artikel" @default.
- Q37739656 description "наукова стаття, опублікована у квітні 2010" @default.
- Q37739656 description "научни чланак" @default.
- Q37739656 description "مقالة علمية نشرت في 28 أبريل 2010" @default.
- Q37739656 name "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 name "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 name "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 type Item @default.
- Q37739656 label "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 label "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 label "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 prefLabel "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 prefLabel "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 prefLabel "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest." @default.
- Q37739656 P1433 Q37739656-6D852B1A-5200-425E-9EB2-264F2BC8603F @default.
- Q37739656 P1476 Q37739656-2AF9387C-84DD-4147-A3E2-1E392A4BD7F1 @default.
- Q37739656 P2093 Q37739656-5DFAB233-0111-4E15-AF0D-D86D09E51447 @default.
- Q37739656 P2093 Q37739656-931B610F-908C-4280-92FB-A13BC75A3361 @default.
- Q37739656 P2093 Q37739656-9BEFB3FB-5624-4A5C-B6EE-84F74A02CA8E @default.
- Q37739656 P2093 Q37739656-D56B759B-924E-4E3A-8509-E986A189CDF9 @default.
- Q37739656 P2093 Q37739656-E40EFED5-1A1F-4F4A-BF8D-E4BB987B0A3A @default.
- Q37739656 P304 Q37739656-F40CAF22-387A-4C65-B0D6-242B4303EAE9 @default.
- Q37739656 P31 Q37739656-5C89E714-889D-40A1-BE4F-D7E49A3A7013 @default.
- Q37739656 P356 Q37739656-239EDE83-6C22-476D-BFD0-5FAE1BE12A3F @default.
- Q37739656 P407 Q37739656-85A37963-51A8-4321-A0C3-1D56627C3A63 @default.
- Q37739656 P433 Q37739656-5F89A7B5-67AC-4BEE-8B40-6759B152ABD7 @default.
- Q37739656 P478 Q37739656-8E353F68-2F1D-42DC-91EB-C9C033E1B38F @default.
- Q37739656 P50 Q37739656-3F6E0A54-506A-4B10-BA25-6DC8CD27D55F @default.
- Q37739656 P577 Q37739656-B5B99EF4-44AF-42A1-A364-ADE0A0523863 @default.
- Q37739656 P698 Q37739656-EA2F9262-C8AF-4123-968D-B3CE7D574223 @default.
- Q37739656 P921 Q37739656-200CFB46-0EE6-4EF2-806C-07B64B1FF3CB @default.
- Q37739656 P921 Q37739656-A6CF4CA1-FF3E-4F22-8BD5-759318B8B9B8 @default.
- Q37739656 P356 J.JVCA.2010.02.018 @default.
- Q37739656 P698 20430647 @default.
- Q37739656 P1433 Q2045295 @default.
- Q37739656 P1476 "Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest" @default.
- Q37739656 P2093 "Daniel Bolliger" @default.
- Q37739656 P2093 "Edward P Chen" @default.
- Q37739656 P2093 "Kenichi A Tanaka" @default.
- Q37739656 P2093 "Roman M Sniecinski" @default.
- Q37739656 P2093 "Sunal S Makadia" @default.
- Q37739656 P304 "959-963" @default.
- Q37739656 P31 Q13442814 @default.
- Q37739656 P356 "10.1053/J.JVCA.2010.02.018" @default.
- Q37739656 P407 Q1860 @default.
- Q37739656 P433 "6" @default.
- Q37739656 P478 "24" @default.
- Q37739656 P50 Q56697442 @default.
- Q37739656 P577 "2010-04-28T00:00:00Z" @default.
- Q37739656 P698 "20430647" @default.
- Q37739656 P921 Q101004 @default.
- Q37739656 P921 Q418666 @default.